Advertisement
Femasys Inc.

Femasys Inc. Fundamental Analysis

FEMYNASDAQ
HealthcareMedical - Instruments & Supplies
$4.44
$0.95(17.57%)
U.S. Market is Open · 12:19
Advertisement

Femasys Inc. Fundamental Analysis

Femasys Inc. (FEMY) shows weak financial fundamentals with a PE ratio of -1.27, profit margin of -5.22%, and ROE of -2.58%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position30.79%
PEG Ratio-0.01
Current Ratio3.91

Areas of Concern

ROE-2.58%
Operating Margin-6.88%
We analyze FEMY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -792.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-792.8/100

We analyze FEMY's fundamental strength across five key dimensions:

Efficiency Score

Weak

FEMY struggles to generate sufficient returns from assets.

ROA > 10%
-75.19%

Valuation Score

Excellent

FEMY trades at attractive valuation levels.

PE < 25
-1.27
PEG Ratio < 2
-0.01

Growth Score

Weak

FEMY faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

FEMY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.65
Current Ratio > 1
3.91

Profitability Score

Weak

FEMY struggles to sustain strong margins.

ROE > 15%
-258.08%
Net Margin ≥ 15%
-5.22%
Positive Free Cash Flow
No

Key Financial Metrics

Is FEMY Expensive or Cheap?

P/E Ratio

FEMY trades at -1.27 times earnings. This suggests potential undervaluation.

-1.27

PEG Ratio

When adjusting for growth, FEMY's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Femasys Inc. at 2.16 times its book value. This may indicate undervaluation.

2.16

EV/EBITDA

Enterprise value stands at -1.02 times EBITDA. This is generally considered low.

-1.02

How Well Does FEMY Make Money?

Net Profit Margin

For every $100 in sales, Femasys Inc. keeps $-5.22 as profit after all expenses.

-5.22%

Operating Margin

Core operations generate -6.88 in profit for every $100 in revenue, before interest and taxes.

-6.88%

ROE

Management delivers $-2.58 in profit for every $100 of shareholder equity.

-2.58%

ROA

Femasys Inc. generates $-75.19 in profit for every $100 in assets, demonstrating efficient asset deployment.

-75.19%

Following the Money - Real Cash Generation

Operating Cash Flow

Femasys Inc. generates limited operating cash flow of $-16.37M, signaling weaker underlying cash strength.

$-16.37M

Free Cash Flow

Femasys Inc. generates weak or negative free cash flow of $-16.83M, restricting financial flexibility.

$-16.83M

FCF Per Share

Each share generates $-5.57 in free cash annually.

$-5.57

FCF Yield

FEMY converts -1.30% of its market value into free cash.

-1.30%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.27

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

6.009

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.65

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.91

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.58

vs 25 benchmark

ROA

Return on assets percentage

-0.75

vs 25 benchmark

ROCE

Return on capital employed

-1.23

vs 25 benchmark

How FEMY Stacks Against Its Sector Peers

MetricFEMY ValueSector AveragePerformance
P/E Ratio-1.2734.27 Better (Cheaper)
ROE-258.08%377.00% Weak
Net Margin-521.78%-42945.00% (disorted) Weak
Debt/Equity0.650.78 Neutral
Current Ratio3.915.54 Strong Liquidity
ROA-75.19%-162.00% (disorted) Weak

FEMY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Femasys Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ